Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Bress

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Pharmacotherapy|May 6, 2017
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart FailureJordan B King, Rashmee U Shah, Amy Sainski-Nguyen, et al.
American Journal of Preventive Cardiology|December 21, 2023
Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020Joshua A Jacobs, Alexander R Zheutlin, Catherine G Derington, et al.
Journal of Clinical Lipidology|August 20, 2023
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013-2020Alexander R Zheutlin, Joshua A Jacobs, Catherine G Derington, et al.
Journal of the American Heart Association|July 14, 2016
Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of StrokeAdam P Bress, Rikki M Tanner, Rachel Hess, et al.
American Journal of Hypertension|March 24, 2023
Discontinuation of Renin-Angiotensin System Inhibitors During the Early Stage of the COVID-19 PandemicPaul Muntner, Kathryn Foti, Zhixin Wang, et al.
American Journal of Hypertension|August 23, 2022
Identification of a SGCD × Discrimination Interaction Effect on Systolic Blood Pressure in African American Adults in the Jackson Heart StudyChu J Hsiao, Leanne Dumeny, Adam P Bress, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2017
Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant AntiretroviralsJoanne LaFleur, Adam P Bress, Stephen Esker, et al.
Current Hypertension Reports|October 14, 2020
Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and ChallengesJaejin An, Catherine G Derington, Tiffany Luong, et al.
Pharmacogenetics and Genomics|December 3, 2014
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African AmericansKatarzyna Drozda, Shan Wong, Shitalben R Patel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2018
The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart StudyMarguerite R Irvin, John N Booth, Mario Sims, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Pharmacotherapy|May 6, 2017
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart FailureJordan B King, Rashmee U Shah, Amy Sainski-Nguyen, et al.
American Journal of Preventive Cardiology|December 21, 2023
Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015-2020Joshua A Jacobs, Alexander R Zheutlin, Catherine G Derington, et al.
Journal of Clinical Lipidology|August 20, 2023
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013-2020Alexander R Zheutlin, Joshua A Jacobs, Catherine G Derington, et al.
Journal of the American Heart Association|July 14, 2016
Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of StrokeAdam P Bress, Rikki M Tanner, Rachel Hess, et al.
American Journal of Hypertension|March 24, 2023
Discontinuation of Renin-Angiotensin System Inhibitors During the Early Stage of the COVID-19 PandemicPaul Muntner, Kathryn Foti, Zhixin Wang, et al.
American Journal of Hypertension|August 23, 2022
Identification of a SGCD × Discrimination Interaction Effect on Systolic Blood Pressure in African American Adults in the Jackson Heart StudyChu J Hsiao, Leanne Dumeny, Adam P Bress, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2017
Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant AntiretroviralsJoanne LaFleur, Adam P Bress, Stephen Esker, et al.
Current Hypertension Reports|October 14, 2020
Fixed-Dose Combination Medications for Treating Hypertension: A Review of Effectiveness, Safety, and ChallengesJaejin An, Catherine G Derington, Tiffany Luong, et al.
Pharmacogenetics and Genomics|December 3, 2014
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African AmericansKatarzyna Drozda, Shan Wong, Shitalben R Patel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2018
The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart StudyMarguerite R Irvin, John N Booth, Mario Sims, et al.
Pageof 16